These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 25007399)

  • 21. Metal-ion-dependent biological properties of a chelator-derived somatostatin analogue for tumour targeting.
    Heppeler A; André JP; Buschmann I; Wang X; Reubi JC; Hennig M; Kaden TA; Maecke HR
    Chemistry; 2008; 14(10):3026-34. PubMed ID: 18246556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors.
    Ginj M; Zhang H; Waser B; Cescato R; Wild D; Wang X; Erchegyi J; Rivier J; Mäcke HR; Reubi JC
    Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16436-41. PubMed ID: 17056720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of a New
    Mansi R; Nicolas GP; Del Pozzo L; Abid KA; Grouzmann E; Fani M
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32932783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and pharmacological characterization of somatostatin receptors in rat lung.
    Schloos J; Raulf F; Hoyer D; Bruns C
    Br J Pharmacol; 1997 Jul; 121(5):963-71. PubMed ID: 9222554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands.
    Reubi JC; Waser B; Schaer JC; Laissue JA
    Eur J Nucl Med; 2001 Jul; 28(7):836-46. PubMed ID: 11504080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Highly potent cyclic disulfide antagonists of somatostatin.
    Hocart SJ; Jain R; Murphy WA; Taylor JE; Coy DH
    J Med Chem; 1999 Jun; 42(11):1863-71. PubMed ID: 10354394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation and biological evaluation of 64Cu-CB-TE2A-sst2-ANT, a somatostatin antagonist for PET imaging of somatostatin receptor-positive tumors.
    Wadas TJ; Eiblmaier M; Zheleznyak A; Sherman CD; Ferdani R; Liang K; Achilefu S; Anderson CJ
    J Nucl Med; 2008 Nov; 49(11):1819-27. PubMed ID: 18927338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological characterisation of native somatostatin receptors in AtT-20 mouse tumour corticotrophs.
    Cervia D; Nunn C; Fehlmann D; Langenegger D; Schuepbach E; Hoyer D
    Br J Pharmacol; 2003 May; 139(1):109-21. PubMed ID: 12746229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bis(Disulfide)-Bridged Somatostatin-14 Analogs and Their [
    Tatsi A; Maina T; Waser B; Krenning EP; de Jong M; Reubi JC; Cordopatis P; Nock BA
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new
    Mansi R; Abid K; Nicolas GP; Del Pozzo L; Grouzmann E; Fani M
    EJNMMI Res; 2020 Aug; 10(1):90. PubMed ID: 32757150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?
    Antunes P; Ginj M; Zhang H; Waser B; Baum RP; Reubi JC; Maecke H
    Eur J Nucl Med Mol Imaging; 2007 Jul; 34(7):982-93. PubMed ID: 17225119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [125I]Tyr10-cortistatin14 labels all five somatostatin receptors.
    Siehler S; Seuwen K; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 1998 May; 357(5):483-9. PubMed ID: 9650799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The glucose-dependent insulinotropic polypeptide receptor: a novel target for neuroendocrine tumor imaging—first preclinical studies.
    Gourni E; Waser B; Clerc P; Fourmy D; Reubi JC; Maecke HR
    J Nucl Med; 2014 Jun; 55(6):976-82. PubMed ID: 24744444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transient expression of somatostatin sst2 receptors in rat cerebellar nuclei during development.
    Bucharles C; Vaudry H; Leroux P
    J Chem Neuroanat; 1999 May; 16(3):223-9. PubMed ID: 10422740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Instant kit preparation of
    Sinnes JP; Nagel J; Waldron BP; Maina T; Nock BA; Bergmann RK; Ullrich M; Pietzsch J; Bachmann M; Baum RP; Rösch F
    EJNMMI Res; 2019 May; 9(1):48. PubMed ID: 31123943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis, and biological evaluation of somatostatin-based radiopeptides.
    Ginj M; Schmitt JS; Chen J; Waser B; Reubi JC; de Jong M; Schulz S; Maecke HR
    Chem Biol; 2006 Oct; 13(10):1081-90. PubMed ID: 17052612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro and in vivo evaluation of 64Cu-TETA-Tyr3-octreotate. A new somatostatin analog with improved target tissue uptake.
    Lewis JS; Srinivasan A; Schmidt MA; Anderson CJ
    Nucl Med Biol; 1999 Apr; 26(3):267-73. PubMed ID: 10363797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Localization and pharmacological characterization of somatostatin recognition sites in the human cerebellum.
    Piwko C; Thoss VS; Probst A; Hoyer D
    Neuropharmacology; 1996 Jun; 35(6):713-23. PubMed ID: 8887980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and evaluation of a ligand targeting the somatostatin-2 receptor for drug delivery to neuroendocrine cancers.
    Li G; Low PS
    Bioorg Med Chem Lett; 2015 Apr; 25(8):1792-1798. PubMed ID: 25791453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective targeting of E. coli heat-stable enterotoxin analogs to human colon cancer cells.
    Giblin MF; Sieckman GL; Watkinson LD; Daibes-Figueroa S; Hoffman TJ; Forte LR; Volkert WA
    Anticancer Res; 2006; 26(5A):3243-51. PubMed ID: 17094436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.